Publikationsrepositorium - Helmholtz-Zentrum Dresden-Rossendorf

Böhlen et al. [1] recently proposed a model that describes the magnitude of the normal tissue sparing Flash effect as a function of dose based on available in vivo data. The newly introduced flash modifying factor FMF translates doses applied at ultra-high dose rate to equivalent doses at conventional dose rate similar to the concept of relative biological effectiveness [1]. Primarily founded on rodent data, the model [1] includes only one study that demonstrated a dose-dependent Flash effect by length differences measured at 5 days-old zebrafish embryo (ZFE) after irradiation with electron doses of 5 – 12 Gy [2]. We studied this systematic overview about the available Flash data with great interest and acknowledged it as a very useful guidance for future Flash research. Coincidentally, we have just recently measured ZFE data in the high dose range (15 – 50 Gy) that appear to match very well with the existing rodent data.
Comparable to our previous studies at the ELBE accelerator [3, 4], one day-old ZFE were irradiated using electron beams of reference (mean dose rate 0.11 Gy/s) and ultra-high dose rate (UHDR; mean dose rate 0.9×105 Gy/s) (Fig. 1a). Normal tissue toxicity was quantified by analyzing the length deficit of the 5 days-old embryos compared to unirradiated controls. Since the controls grew on average 30% from irradiation to analysis this is the maximum length deficit that can be caused by irradiation. The derived FMF values extend the available ZFE data [2] and cover in a single experiment almost the entire dose range applied in the rodent studies for different tissues. Comparable to the rodent data (Fig. 1b) the ZFE FMF increases with dose.
The good agreement of our ZFE data with the rodent data [1] demonstrates the feasibility of the ZFE model for basic Flash effect studies, e.g., on the influence of physical beam parameters [3–6]. Hence, the ZFE model could be deployed as a high-throughput alternative to rodent studies at this translational level [5] promising the exploration of a large dose and dose rate range of clinically relevant beams.